Nephrogen (Founding)

Funding Details
Awarder
YCombinator
Date Award
August 18, 2022
Vertical
Healthcare,Therapeutics
Funding URL
View Funding Page
Valuation
$0

Company Info
Founding Year
2022
Company Description
We're building curative gene therapies for kidney diseases. Our initial focus is on polycystic kidney disease (PKD), which affects 600,000 Americans and has no effective treatment or cure.
Market
Healthcare
Coinvestors
YCombinator

Links
Back to Home Back to Healthcare,Therapeutics Deals View Funding Announcement